Literature DB >> 25330924

Epigenomics and the microbiota.

Theresa Alenghat1.   

Abstract

The mammalian gastrointestinal tract is home to trillions of commensal microorganisms that collectively make up the intestinal microbiota. These microbes are important environmental factors that regulate homeostasis, and alterations in the composition of the microbiota have been associated with several diseases, including inflammatory bowel disease, diabetes, and cancer. New research is beginning to uncover epigenomic pathways that may regulate this relationship with the microbiota. Epigenomic modifications alter the structure of the chromatin and therefore regulate the transcriptional program of a cell. These modifications are maintained by the dynamic activity of various modifying and demodifying enzymes, the activities of which can be influenced by metabolites and other environmental cues. Histone deacetylases (HDACs) are a class of epigenomic-modifying enzymes that are regulated by both endogenous and exogenous factors, and recent studies have suggested that host HDAC expression is important for regulating communication between the intestinal microbiota and mammalian host cells.
© 2014 by The Author(s).

Entities:  

Keywords:  HDAC; butyrate.; epigenomics; microbiota

Mesh:

Year:  2014        PMID: 25330924      PMCID: PMC4310797          DOI: 10.1177/0192623314553805

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  69 in total

Review 1.  Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics.

Authors:  Anton Eberharter; Peter B Becker
Journal:  EMBO Rep       Date:  2002-03       Impact factor: 8.807

2.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

3.  Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.

Authors:  Edwin F de Zoeten; Liqing Wang; Hong Sai; Wolfgang H Dillmann; Wayne W Hancock
Journal:  Gastroenterology       Date:  2009-10-29       Impact factor: 22.682

4.  Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.

Authors:  Myung H Kim; Seung G Kang; Jeong H Park; Masashi Yanagisawa; Chang H Kim
Journal:  Gastroenterology       Date:  2013-05-07       Impact factor: 22.682

5.  Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages.

Authors:  Xuefen Chen; Iros Barozzi; Alberto Termanini; Elena Prosperini; Antonio Recchiuti; Jesmond Dalli; Flore Mietton; Gianluca Matteoli; Scott Hiebert; Gioacchino Natoli
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

Review 6.  Genomic views of STAT function in CD4+ T helper cell differentiation.

Authors:  John J O'Shea; Riitta Lahesmaa; Golnaz Vahedi; Arian Laurence; Yuka Kanno
Journal:  Nat Rev Immunol       Date:  2011-04       Impact factor: 53.106

7.  Intestinal inflammation targets cancer-inducing activity of the microbiota.

Authors:  Janelle C Arthur; Ernesto Perez-Chanona; Marcus Mühlbauer; Sarah Tomkovich; Joshua M Uronis; Ting-Jia Fan; Barry J Campbell; Turki Abujamel; Belgin Dogan; Arlin B Rogers; Jonathan M Rhodes; Alain Stintzi; Kenneth W Simpson; Jonathan J Hansen; Temitope O Keku; Anthony A Fodor; Christian Jobin
Journal:  Science       Date:  2012-08-16       Impact factor: 47.728

Review 8.  Dietary histone deacetylase inhibitors: from cells to mice to man.

Authors:  Roderick H Dashwood; Emily Ho
Journal:  Semin Cancer Biol       Date:  2007-05-05       Impact factor: 15.707

Review 9.  Epigenetic regulation of asthma and allergic disease.

Authors:  Philippe Bégin; Kari C Nadeau
Journal:  Allergy Asthma Clin Immunol       Date:  2014-05-28       Impact factor: 3.406

10.  Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.

Authors:  Nicholas Arpaia; Clarissa Campbell; Xiying Fan; Stanislav Dikiy; Joris van der Veeken; Paul deRoos; Hui Liu; Justin R Cross; Klaus Pfeffer; Paul J Coffer; Alexander Y Rudensky
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

View more
  14 in total

Review 1.  Epigenome-based cancer risk prediction: rationale, opportunities and challenges.

Authors:  Martin Widschwendter; Allison Jones; Iona Evans; Daniel Reisel; Joakim Dillner; Karin Sundström; Ewout W Steyerberg; Yvonne Vergouwe; Odette Wegwarth; Felix G Rebitschek; Uwe Siebert; Gaby Sroczynski; Inez D de Beaufort; Ineke Bolt; David Cibula; Michal Zikan; Line Bjørge; Nicoletta Colombo; Nadia Harbeck; Frank Dudbridge; Anne-Marie Tasse; Bartha M Knoppers; Yann Joly; Andrew E Teschendorff; Nora Pashayan
Journal:  Nat Rev Clin Oncol       Date:  2018-02-27       Impact factor: 66.675

2.  Murine Genetic Background Has a Stronger Impact on the Composition of the Gut Microbiota than Maternal Inoculation or Exposure to Unlike Exogenous Microbiota.

Authors:  Hila Korach-Rechtman; Shay Freilich; Shiran Gerassy-Vainberg; Keren Buhnik-Rosenblau; Yael Danin-Poleg; Haim Bar; Yechezkel Kashi
Journal:  Appl Environ Microbiol       Date:  2019-08-29       Impact factor: 4.792

3.  Microbes As Friends, Not Foes: Shifting the Focus from Pathogenesis to Symbiosis.

Authors:  Sheila A Homburger; Dina Drits-Esser; Molly Malone; Louisa A Stark
Journal:  Am Biol Teach       Date:  2015 Nov-Dec       Impact factor: 0.342

4.  Strain-specific effects of probiotic Lactobacilli on mRNA expression of epigenetic modifiers in intestinal epithelial cells.

Authors:  Ankita Kumari; Shalaka Bhawal; Suman Kapila; Rajeev Kapila
Journal:  Arch Microbiol       Date:  2022-06-21       Impact factor: 2.552

Review 5.  Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases.

Authors:  Tatiana Y Fofanova; Joseph F Petrosino; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-02       Impact factor: 2.839

Review 6.  The interplay between diet, gut microbes, and host epigenetics in health and disease.

Authors:  Tori Shock; Luis Badang; Bradley Ferguson; Kristina Martinez-Guryn
Journal:  J Nutr Biochem       Date:  2021-03-28       Impact factor: 6.117

7.  The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms.

Authors:  Canhua Xiao; Veronika Fedirko; Jonathan Beitler; Jinbing Bai; Gang Peng; Chao Zhou; Jianlei Gu; Hongyu Zhao; I-Hsin Lin; Cynthia E Chico; Sangchoon Jeon; Tish M Knobf; Karen N Conneely; Kristin Higgins; Dong M Shin; Nabil Saba; Andrew Miller; Deborah Bruner
Journal:  Support Care Cancer       Date:  2020-10-20       Impact factor: 3.359

8.  Approaches to studying and manipulating the enteric microbiome to improve autism symptoms.

Authors:  Richard E Frye; John Slattery; Derrick F MacFabe; Emma Allen-Vercoe; William Parker; John Rodakis; James B Adams; Rosa Krajmalnik-Brown; Ellen Bolte; Stephen Kahler; Jana Jennings; Jill James; Carl E Cerniglia; Tore Midtvedt
Journal:  Microb Ecol Health Dis       Date:  2015-05-07

Review 9.  The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood.

Authors:  John Slattery; Derrick F MacFabe; Richard E Frye
Journal:  Clin Med Insights Pediatr       Date:  2016-10-09

Review 10.  Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Clin Med Insights Pediatr       Date:  2016-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.